These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23008880)

  • 1. Atrial fibrillation--not so NICE in Ireland!
    Collins DR; Coughlan T
    Ir Med J; 2012; 105(7):229-31. PubMed ID: 23008880
    [No Abstract]   [Full Text] [Related]  

  • 2. New directions in anticoagulation.
    Alpert JS
    Am J Med; 2012 Mar; 125(3):217-8. PubMed ID: 22340912
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral anticoagulants for atrial fibrillation: Which one to choose?
    Ribowsky JH; Ismael AG
    Adv NPs PAs; 2012 May; 3(5):31-2. PubMed ID: 22670305
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Berg AM
    Ann Intern Med; 2011 Apr; 154(8):570; author reply 570-1. PubMed ID: 21502659
    [No Abstract]   [Full Text] [Related]  

  • 5. Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers.
    Fanikos J
    J Med Econ; 2013 Oct; 16(10):1190-2. PubMed ID: 23919663
    [No Abstract]   [Full Text] [Related]  

  • 6. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Edwards DB; Silverberg J
    Ann Intern Med; 2011 Apr; 154(8):570; author reply 570-1. PubMed ID: 21502658
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation choices. Picking an anti-clotting drug.
    Mayo Clin Health Lett; 2014 Jun; 32(6):4-5. PubMed ID: 25029747
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of novel anticoagulants and potential economic implications.
    Nutescu E
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S27-32. PubMed ID: 21517653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
    Ahrens I; Lip GY; Peter K
    Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
    [No Abstract]   [Full Text] [Related]  

  • 11. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
    Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
    J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Help prevent Afib-related stroke. New anticoagulants for atrial fibrillation prove as effective, or even better than, warfarin--and easier to use.
    Duke Med Health News; 2014 Sep; 20(9):3. PubMed ID: 25358137
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran in atrial fibrillation: incremental benefit over a time horizon of 5 or 10 years.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):683-5. PubMed ID: 23032961
    [No Abstract]   [Full Text] [Related]  

  • 14. A new era for anticoagulation in atrial fibrillation.
    Mega JL
    N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
    Morales-Vidal S; Schneck MJ; Flaster M; Biller J
    Expert Rev Neurother; 2012 Feb; 12(2):179-89; quiz 190. PubMed ID: 22288673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation: what the GP needs to know].
    Diener HC; Kaeufer T; Bode C
    MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract]   [Full Text] [Related]  

  • 17. [New anticoagulants: better knowledge, better prescriptions].
    Boehlen F; de Moerloose P
    Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
    Tripodi A; Palareti G
    J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian MPs demand more data on dabigatran for atrial fibrillation.
    Brill D
    BMJ; 2013 Jan; 346():f303. PubMed ID: 23321733
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation.
    LaHaye SA; Gibbens SL; Ball DG; Day AG; Olesen JB; Skanes AC
    Eur Heart J; 2012 Sep; 33(17):2163-71. PubMed ID: 22752615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.